Delivery Order SPE2DR25D3301-SPE2DR26F23TM
Award Date 3/9/26
Potential Completion Date 3/30/26
Potential Value $17K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 6, 2026, for Ibrance 125 mg capsule 21-count units with a ceiling value of $8,555.21. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order has a firm fixed-price structure...
- <p>The Defense Logistics Agency issued a $25,665.63 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for supply of Ibrance 125 mg capsule (21-count packages) with an ultimate completion date of March 26, 2026.</p> <p>The order is issued under a parent Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency issued a $8,555.21 delivery order to AmerisourceBergen Drug Corp on March 2, 2026, for supply of Ibrance 125 mg capsules (21-count packages). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order has a firm fixed price and an...
- The Defense Logistics Agency issued a $8,561.41 delivery order to Amerisourcebergen Drug Corp on March 5, 2026, for Ibrance 75 mg capsule 21-count units, with ultimate completion on March 26, 2026. The order is issued under the DLA Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract through December 2026 that provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Pricing is firm fixed...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 17, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 10, 2026, and is priced as firm fixed price with no set-aside. The delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which supports pharmaceutical supply...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 20, 2026, for Ibrance 125 mg capsule 21-count units, with a ceiling value of $8,555.21. Place of performance is Conshohocken, PA. The order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. Ultimate completion date is March 13, 2026. Pricing is firm fixed price under a non-set-aside competitive...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Ibrance 100 mg capsule (21-count), with a ceiling value of $8,559.84. Place of performance is Conshohocken, PA. Ultimate completion date is March 26, 2026. The order was issued under firm fixed-price terms with no set-aside. This delivery order is called against AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to...
- The Defense Logistics Agency issued a $8,559.84 delivery order to Amerisourcebergen Drug Corp on February 24, 2026, for Ibrance 100 mg tablets. Place of performance is Conshohocken, PA. The order has an ultimate completion date of March 17, 2026. Pricing is firm fixed price. The order was issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December 2026, which supports global pharmaceutical supply to military healthcare...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on March 2, 2026, for Ibrance 125 mg capsules (21-count), with a ceiling value of $8,555.21. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 and running through December 2026.</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is March 23, 2026. Pricing is firm fixed price. No set-aside was applied.</p>
- The Defense Logistics Agency issued a $25,665.63 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for supply of Ibrance 125 mg tablets (7s). This delivery order is issued under the DLA Troop Support Medical indefinite delivery contract (IDC) with Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 2026. The contract provides pharmaceutical and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken,...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F23TMDelivery Order
The Defense Logistics Agency issued a $17,119.68 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for Ibrance 100 mg capsule (21-count packaging). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a comprehensive global pharmaceutical supply vehicle valued up to $999,999,999 through December 2026. Place of performance is Conshohocken, PA. The order carries a firm fixed price and an ultimate completion date of March 30, 2026. No set-aside applies.
Generated 6/7/26, 9:42 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.1k | 3/8/26 |